Verona Pharma (NASDAQ:VRNA) Price Target Raised to $85.00
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target lifted by HC Wainwright from $75.00 to $85.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s Q2 2025 earnings at ($0.08) EPS, Q3 2025 earnings at […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its price target lifted by HC Wainwright from $75.00 to $85.00 in a research note published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s Q2 2025 earnings at ($0.08) EPS, Q3 2025 earnings at […]
